Analysis of 629 pregnancy outcomes in transplant recipients treated with sandimmun
References (3)
- et al.
Am J Obstet Gynecol
(1988)
There are more references available in the full text version of this article.
Cited by (78)
Management of Psoriasis During Preconception, Pregnancy, Postpartum, and Breastfeeding: A Consensus Statement
2021, Actas Dermo-SifiliograficasPsoriasis: Which therapy for which patient: Focus on special populations and chronic infections
2019, Journal of the American Academy of DermatologyCyclosporine
2016, Therapy for Severe PsoriasisManagement of rheumatic and autoimmune blistering disease in pregnancy and postpartum
2016, Clinics in DermatologyCitation Excerpt :Cyclosporine can diffuse across the placenta, enter fetal circulation, and increase fetal exposure to other drugs.41,42 Congenital malformations have not been observed,42,43 but low birth weight and prematurity have been reported.4,44–46 Although the use of cyclosporine in pregnancy is not recommended, it can be useful in severe disease.
Drug safety: Pregnancy rating classifications and controversies
2016, Clinics in DermatologyCitation Excerpt :Cyclosporine (Category C) can cross the placenta but has not been associated with congenital malformations. Low birth weight and prematurity have been reported.22,47 It is unclear whether these risks are associated with cyclosporine use or with the underlying disease for which the medication is prescribed.
Immunosuppression, rheumatic diseases, multiple sclerosis, and Wilson's disease
2015, Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment: Third Edition
Copyright © 1997 Published by Elsevier Inc. All rights reserved.